These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15686938)

  • 21. Synthesis of dihydrofuroaporphine derivatives: identification of a potent and selective serotonin 5-HT 1A receptor agonist.
    Liu Z; Zhang H; Ye N; Zhang J; Wu Q; Sun P; Li L; Zhen X; Zhang A
    J Med Chem; 2010 Feb; 53(3):1319-28. PubMed ID: 20041669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of alpha 1 antagonist WB-4101.
    Bolchi C; Catalano P; Fumagalli L; Gobbi M; Pallavicini M; Pedretti A; Villa L; Vistoli G; Valoti E
    Bioorg Med Chem; 2004 Sep; 12(18):4937-51. PubMed ID: 15336273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
    Ivorra MD; Valiente M; Martínez S; Madrero Y; Noguera MA; Cassels BK; Sobarzo EM; D'Ocon P
    Planta Med; 2005 Oct; 71(10):897-903. PubMed ID: 16254819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
    Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
    J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
    Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding.
    Odagaki Y; Toyoshima R; Yamauchi T
    J Psychopharmacol; 2005 May; 19(3):235-41. PubMed ID: 15888508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype.
    Knepper SM; Buckner SA; Brune ME; DeBernardis JF; Meyer MD; Hancock AA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):97-103. PubMed ID: 7616455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of alpha1-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens.
    Buccioni M; Kandhavelu M; Angeli P; Cristalli G; Dal Ben D; Giardinà D; Lambertucci C; Lammi C; Volpini R; Marucci G
    Eur J Pharmacol; 2009 Jan; 602(2-3):388-94. PubMed ID: 19041301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonists.
    Halazy S; Perez M; Fourrier C; Pallard I; Pauwels PJ; Palmier C; John GW; Valentin JP; Bonnafous R; Martinez J
    J Med Chem; 1996 Dec; 39(25):4920-7. PubMed ID: 8960551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.
    Giardinà D; Crucianelli M; Romanelli R; Leonardi A; Poggesi E; Melchiorre C
    J Med Chem; 1996 Nov; 39(23):4602-7. PubMed ID: 8917649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3292-7. PubMed ID: 17452102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
    Romeo G; Materia L; Manetti F; Cagnotto A; Mennini T; Nicoletti F; Botta M; Russo F; Minneman KP
    J Med Chem; 2003 Jul; 46(14):2877-94. PubMed ID: 12825930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist.
    Altenbach RJ; Khilevich A; Kolasa T; Rohde JJ; Bhatia PA; Patel MV; Searle XB; Yang F; Bunnelle WH; Tietje K; Bayburt EK; Carroll WA; Meyer MD; Henry R; Buckner SA; Kuk J; Daza AV; Milicic IV; Cain JC; Kang CH; Ireland LM; Carr TL; Miller TR; Hancock AA; Nakane M; Esbenshade TA; Brune ME; O'Neill AB; Gauvin DM; Katwala SP; Holladay MW; Brioni JD; Sullivan JP
    J Med Chem; 2004 Jun; 47(12):3220-35. PubMed ID: 15163201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New 5-HT(1A) receptor ligands containing a N'-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Santagada V; Caliendo G
    Bioorg Med Chem Lett; 2010 May; 20(9):2978-82. PubMed ID: 20347301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors.
    Schurad B; Horowski R; Jähnichen S; Görnemann T; Tack J; Pertz HH
    Life Sci; 2006 Apr; 78(20):2358-64. PubMed ID: 16310806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3930-4. PubMed ID: 17517507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor.
    Markowitz JS; DeVane CL; Ramamoorthy S; Zhu HJ
    Pharmazie; 2009 Feb; 64(2):123-5. PubMed ID: 19322953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of the 5-hydroxytryptamine (5-HT)1A receptor inverse agonists Rec 27/0224 and Rec 27/0074 on electrophysiological responses to 5-HT1A receptor activation in rat dorsal raphe nucleus and hippocampus in vitro.
    Corradetti R; Mlinar B; Falsini C; Pugliese AM; Cilia A; Destefani C; Testa R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):109-17. PubMed ID: 15951403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.